Minova Life Science

Minova life sciences - Pharmaceutical company

Tampace-D Tablets

COMPOSITION – Tamsulosin HCL IP 0.4mg + Dutasteride 0.5mg

  • More effective for the treatment of symptomatic benign prostatic hyperplasia than either drug alone
  • Reduces the risk of developing acute urinary retention and need for surgery in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement
  • Reduces symptoms of BPH, improves urinary flow and reduces prostate size in benign prostatic hyperplasia
  • Provides better improvement of IPSS obstructive symptoms, UFR and reduction in PVRU than observed with the Tamsulosin and Finasteride
  • More effectively provides greater degree of benefit in men with moderate to severe lower urinary tract symptoms and prostate enlargement

Explore other products

Scroll to Top